High frequency of apolipoprotem E ε2 allele in hemorrhage due to cerebral amyloid angiopathy

Annals of Neurology

Volumn 41, Issue 6, 1997, Pages 716-721

  Nicoll, James A R ^a,e   Burnett, Claire ^a   Love, Seth ^b   Graham, David I ^a   Dewar, Debbie ^a   Ironside, James W ^c   Stewart, Janice ^a   Vinters, Harry V ^d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d UCLA MEDICAL CENTER   (United States)

^e SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR AMYLOIDOSIS; ALLELE; GENETICS; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEINS E; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED;

EID: 0030610591     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410607     Document Type: Article

References (35)

1. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324
2. Vonsattel JPG, Myers RH, HedleyWhyre ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991;30:637-649
3. Vinters HV, Wang ZZ, Secor DL. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996; 6:179-195
4. Coria F, Castano EM, Frangione B. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease β-protein. Am J Pathol 1987;129:422-428
5. Pardridge WM, Vinters HV, Yang J, et al. Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels. J Neurochem 1987;49:1394-1401
6. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653
7. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580
8. Berr C, Hauw JJ, Delaere P, et al. Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid β-peptide (Aβ) in cases with or without Alzheimer's disease. Neurosci Lett 1994; 178:221-224
9. Hyman BT, Gomezlsla T, West H, et al. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Ann NY Acad Sci 1996;777:158-165
10. Nicoll JAR, Roberts GW, Graham DI. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med 1995;1:135-137
11. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102
12. Ma J, Yee A, Brewer HB Jr, et al. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-94
13. Wisniewski T, Castano EM, Golabek A, et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-1035
14. LaDu MJ, Pederson TM, Frail DE, et al. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 1995;270:9039-9042
15. Greenberg SM, Rebeck GW, Vonsattel JPG, et al. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-259
16. Premkumar DRD, Cohen DL, Hedera P, et al. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-2095
17. Kalaria RN, Cohen DL, Premkumar DRD. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease. Ann NY Acad Sci 1996;777:266-270
18. Kalaria RN, Premkumar DRD. Apolipoprotein E genotype and cerebral amyloid angiopathy. Lancet 1995;346:1424 (letter)
19. Greenberg SM, Briggs ME, Hyman BT, et al. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996;27:1333-1337
20. Itoh Y, Yamada M, Suematsu N, et al. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke 1996;27:216-218
21. Nicoll JAR, Burnett C, Love S, et al. High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1996;39:682-683 (Letter)
22. Vinters HV. Cerebral amyloid angiopathy and Alzheimer's disease: two entities or one? J Neurol Sci 1992;112:1-3
23. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754
24. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
25. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699
26. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
27. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994;7:180-184
28. West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994;175:46-48
29. Talbot C, Lendon C, Craddock N, et al. Protection against Alzheimer's disease with apoE ε2. Lancet 1994:343:1432-1433
30. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment ot Alzheimer's disease. Neurology 1991;41:479-486
31. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159
32. Dewar D, Chalmers DT, Graham DI, et al. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus. Brain Res 1991:553:58-64
33. Haan J, Roos RAC, Bakker E. No protective effect of apolipoprotein E epsilon 2 allele in Dutch hereditary cerebral amyloid angiopathy. Ann Neurol 1995;37:282 (letter)
34. Yamada M, Itoh Y, Suematsu N, et al. Lack of an association between apolipoprotein E ε4 and cerebral amyloid angiopathy in elderly Japanese. Ann Neurol 1996:39:683-684 (letter)
35. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21